Blog
Adult social care services
PRN (pro re nata) medicines, also known as ‘when required’ medicines, are medicines with a ‘when required’ dose that can treat many different conditions (examples include nausea and vomiting, pain, indigestion, constipation, anxiety and insomnia).
Additional Pharmacy Regulatory Changes
Several regulatory changes are due to come into effect today (1st October 2025), having been included in the amendment regulations laid before Parliament last week (The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025).
DSPs: Service Changes from 1st October 2025
DSP (Distance selling premises) pharmacies will no longer be able to provide Directed services (Advanced, National Enhanced and Enhanced Services) face-to-face with patients at the pharmacy premises from today (1st October 2025).
ABPM bundling requirement to be delayed
DHSC, NHS England and Community Pharmacy England have agreed that the requirement to provide one Ambulatory Blood Pressure Monitoring (ABPM) consultation per month as part of the ‘bundling’ requirements to achieve Pharmacy First fixed monthly payment will not go ahead from 1st October 2025 as originally planned.
Adult Flu Season: Signing up to the correct PGD
Is your pharmacy ready for the eligible adults being able to access an NHS flu vaccination from the 1st October 2025?
MHRA Green Guide – 2025 Update?
Pharmacists need to check their Professional Indemnity Insurance to ensure that it covers them for the services they are providing, and to ensure that the level of cover is sufficient.
Communication from the GPhC regarding Regulatory Concerns
Communication from the GPhC regarding Regulatory Concerns Regarding the Supply and Promotion of Weight-Management Medicines – Mounjaro®, Wegovy® and Related GLP-1 Therapies
Professional Indemnity Insurance
Pharmacists need to check their Professional Indemnity Insurance to ensure that it covers them for the services they are providing, and to ensure that the level of cover is sufficient.
FDA Warning Letters
The MHRA has reviewed its current approach to contacting UK Licence Holders who may be implicated by USFDA Warning Letters
Emerging issues – Communique from the GPhC
As part of maintaining professional vigilance and regulatory compliance across pharmacy services, PCL would like to draw attention to several critical issues recently highlighted by the General Pharmaceutical Council (GPhC).
New MHRA/NICE Collaboration
The UK is entering a new phase of innovation in how it regulates, assesses, and adopts new medicines—and it’s a development the global pharmaceutical and biopharmaceutical industry cannot afford to overlook.
The Future of Pharmacy first
Pharmacists, remember to direct their virtual patients to the Pharmacy First Survey to leave their feedback on the service.